INS and Hyperglycemia: Preclinical studies in mouse models indicate that PI3Kα inhibition reduces glucose uptake in insulin-responsive tissues such as adipose tissue and muscle, resulting in hyperglycemia and compensatory insulin release from the pancreas, which diminishes the effect of PI3K inhibition [189].